NIH-funded research R21 grant

Investigating genetic changes in a neuromuscular disease affecting men.

Official title: Somatic instability of CAG repeats in spinal and bulbar muscular atrophy

Funded at Thomas Jefferson University · NIH-11119471 · Data updated 2026-11-12

This study is looking at spinal and bulbar muscular atrophy (SBMA) to understand how the genetic changes cause problems in the nerves and muscles, with the hope of finding new ways to help manage symptoms and slow down the disease for those affected.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionThomas Jefferson University
NIH-funded
Lab location1 site (Philadelphia, United States)
Project startMay 15, 2025
Project endApril 30, 2027
Funding year2025
Award (this year)$429,000
NIH project number1R21NS142744-01
Project IDNIH-11119471 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are adult men diagnosed with spinal and bulbar muscular atrophy.

Less likely to help

Patients with other forms of neuromuscular diseases unrelated to androgen receptor mutations may not benefit from this research.

What this research studies

This research focuses on spinal and bulbar muscular atrophy (SBMA), a genetic neuromuscular disease caused by the expansion of a specific nucleotide sequence in the androgen receptor gene. The study utilizes advanced cell and mouse models to explore how these genetic changes lead to neuronal dysfunction and disease progression. By understanding the mechanisms behind SBMA, the research aims to identify potential therapeutic strategies that could alleviate symptoms or slow disease progression. Patients may benefit from insights gained into the disease's pathology and the development of targeted treatments.

Why it matters

Potential benefit: If successful, this research could lead to new therapies that improve the quality of life for patients with spinal and bulbar muscular atrophy.

How similar studies have gone: Previous research on similar genetic mechanisms in other neurodegenerative diseases has shown promising results, indicating potential for success in this area as well.

Where this research is happening

  • Thomas Jefferson University
    Philadelphia, United States
    Active

Researchers

  • Principal investigator: Merry, Diane E — Thomas Jefferson University
  • Study coordinator: Merry, Diane E

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.